• Subscribe
  • Advertise
  • Contact Us
June 17, 2025
Pharma News HQ


  • Home
  • News
  • Clinical Trials
  • Drug Development
  • Manufacturing
  • Packaging and Labeling
  • Cold Chain
  • Diseases
  • Technology
  • Press Feed
    • Articles
    • Press Releases
  • Events
Top Headlines
  • [ February 14, 2023 ] Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues Manufacturing
  • [ February 14, 2023 ] Genenta Science signs manufacturing deal with AGC Biologics Manufacturing
  • [ February 14, 2023 ] Vial and Egnyte announce partnership for eTMF solution integration Clinical Trials
  • [ February 14, 2023 ] SOPHiA GENETICS and AstraZeneca partner for oncology drugs development Drug Development
  • [ February 14, 2023 ] FDA suggests ways to curb constraints with rare disease gene therapy trials Clinical Trials
Home2018July

Month: July 2018

News

UVA Develops Way to Create Medicines Free of Side Effects

July 11, 2018 Pharma News HQ 0

Researchers at the University of Virginia (UVA) have developed a new approach to facilitate the formulation of safer, effective and side effect-free drugs. The technique is based on the accurate targeting of cell molecules associated […]

Diseases

Surgeons may influence genetic testing for breast cancer

July 11, 2018 Pharma News HQ 0

The attending surgeon is associated with variation in the receipt of genetic testing after breast cancer diagnosis, according to a study published online July 3 in JAMA Surgery.   Steven J. Katz, M.D., M.P.H., from […]

Drug Development

Nobel prize-winning technology reveals common herpes virus structure

July 11, 2018 Pharma News HQ 0

Researchers from the University of Glasgow have used Nobel prize-winning cryo-electron microscopy (cryo-EM) to reveal the molecular structure of the common herpes virus in high definition. The capsid, which stores the virus’ DNA, has been […]

Diseases

Blood pressure drug verapamil restores beta cell function in new-onset type 1 diabetes

July 10, 2018 Pharma News HQ 0

A human clinical trial has found that common blood pressure drug called verapamil can decrease insulin requirements and hypoglycaemic episodes in adults with recent onset type 1 diabetes.The study, conducted by the University of Alabama […]

Drug Development

Herantis Announces New Program to Develop Non-Invasive CDNF for Parkinson’s Treatment

July 10, 2018 Pharma News HQ 0

Finnish drug development firm Herantis Pharma has launched a new programme for the development of a non-invasive cerebral dopamine neurotrophic factor (CDNF) to treat patients with Parkinson’s disease.CDNF is a potent neuroprotective factor which promotes […]

Posts pagination

« 1 … 6 7 8 … 12 »



















  • Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

    February 14, 2023 0
  • Genenta Science signs manufacturing deal with AGC Biologics

    February 14, 2023 0
  • Vial and Egnyte announce partnership for eTMF solution integration

    February 14, 2023 0
  • SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

    February 14, 2023 0
  • FDA suggests ways to curb constraints with rare disease gene therapy trials

    February 14, 2023 0
Pharma News HQ

Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production.

 

About Us

 

Subscribe

 

Contact US

Latest Post
  • Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

    February 14, 2023 0
  • Genenta Science signs manufacturing deal with AGC Biologics

    February 14, 2023 0
  • Vial and Egnyte announce partnership for eTMF solution integration

    February 14, 2023 0
  • SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

    February 14, 2023 0
  • FDA suggests ways to curb constraints with rare disease gene therapy trials

    February 14, 2023 0